EA201200604A1 - Фармацевтические субстанции на основе митохондриальноадресованных антиоксидантов - Google Patents
Фармацевтические субстанции на основе митохондриальноадресованных антиоксидантовInfo
- Publication number
- EA201200604A1 EA201200604A1 EA201200604A EA201200604A EA201200604A1 EA 201200604 A1 EA201200604 A1 EA 201200604A1 EA 201200604 A EA201200604 A EA 201200604A EA 201200604 A EA201200604 A EA 201200604A EA 201200604 A1 EA201200604 A1 EA 201200604A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical substances
- mitochondrial
- basis
- substances
- mitochondria
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 4
- 239000003963 antioxidant agent Substances 0.000 title abstract 3
- 230000002438 mitochondrial effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000003860 storage Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/02—Quinones with monocyclic quinoid structure
- C07C50/04—Benzoquinones, i.e. C6H4O2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
- C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
- C07C46/06—Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/10—Quinones the quinoid structure being part of a condensed ring system containing two rings
- C07C50/12—Naphthoquinones, i.e. C10H6O2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B69/00—Dyes not provided for by a single group of this subclass
- C09B69/001—Dyes containing an onium group attached to the dye skeleton via a bridge
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
- G01N33/5079—Mitochondria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Abstract
Данное изобретение относится к области фармацевтики, медицины и, в частности, касается получения и использования фармацевтических субстанций на основе митохондриальноадресованных соединений. Изобретение раскрывает способы синтеза, очистки и хранения митохондриальноадресованных антиоксидантов, позволяющих получать эти вещества в виде и качестве, соответствующим требованиям, предъявляемым к действующим веществам лекарственных препаратов - фармацевтическим субстанциям. Также изобретение раскрывает методы конструирования и отбора новых митохондриальноадресованных антиоксидантов с заданными свойствами.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU2009/000621 WO2011059355A1 (ru) | 2009-11-13 | 2009-11-13 | Фармацевтические субстанции на основе митохондриально-адресованных антиоксидантов |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201200604A1 true EA201200604A1 (ru) | 2012-09-28 |
EA023248B1 EA023248B1 (ru) | 2016-05-31 |
Family
ID=43991821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201200604A EA023248B1 (ru) | 2009-11-13 | 2009-11-13 | Фармацевтические субстанции на основе митохондриально-адресованных антиоксидантов |
Country Status (14)
Country | Link |
---|---|
US (1) | US9233903B2 (ru) |
EP (1) | EP2500336A1 (ru) |
JP (1) | JP2013510849A (ru) |
KR (1) | KR20120125980A (ru) |
CN (1) | CN102791670A (ru) |
AU (1) | AU2009355359B2 (ru) |
BR (1) | BR112012011197A2 (ru) |
CA (2) | CA2789846C (ru) |
EA (1) | EA023248B1 (ru) |
IL (1) | IL219533A (ru) |
MX (1) | MX2012005356A (ru) |
UA (1) | UA107476C2 (ru) |
WO (1) | WO2011059355A1 (ru) |
ZA (1) | ZA201203345B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6448366B2 (ja) * | 2011-06-03 | 2019-01-09 | ミトテック ソシエテ アノニム | ミトコンドリアを標的とする抗酸化剤の経口製剤ならびにそれらの調製および使用 |
WO2015063553A2 (en) | 2013-04-11 | 2015-05-07 | Mitotech S.A. | Mitochondrially-targeted timoquinones and toluquinones |
WO2019002936A2 (en) | 2017-06-26 | 2019-01-03 | Mitotech S.A. | SET OF COMPOUNDS TARGETING MITOCHONDRIA |
CN109232219A (zh) * | 2018-11-11 | 2019-01-18 | 苏州怡彼得生物技术有限公司 | 一种线粒体靶向抗氧化剂skq1中间体2,3-二甲基-对苯醌的合成方法 |
CN109232216A (zh) * | 2018-11-11 | 2019-01-18 | 苏州怡彼得生物技术有限公司 | 一种线粒体靶向抗氧化剂skq1二季膦盐衍生物的合成方法 |
CN109900652B (zh) * | 2019-04-29 | 2021-06-04 | 北京普赞生物技术有限公司 | 一种食品中双乙酸钠的快速检测方法 |
KR102527406B1 (ko) | 2021-01-15 | 2023-04-28 | 아주대학교산학협력단 | 미토콘드리아 기능 장애 관련 질환 예방 또는 치료용 조성물 |
KR102410556B1 (ko) | 2020-01-16 | 2022-06-20 | 아주대학교산학협력단 | 미토콘드리아 타겟팅용 펩타이드 |
EP4210695A1 (en) | 2020-09-09 | 2023-07-19 | Social Profit Network | Methods and compositions for delivery of biotin to mitochondria |
WO2023220365A1 (en) * | 2022-05-13 | 2023-11-16 | Virginia Tech Intellectual Properties, Inc. | Mitochondrial antioxidant treatment for cask-linked neurodevelopmental disorders |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538974A (en) | 1994-01-27 | 1996-07-23 | Senju Pharamceutical Co., Ltd. | Ophthalmic composition for lowering intraocular pressure |
US6331532B1 (en) | 1998-11-25 | 2001-12-18 | University Of Otago | Mitochondrially targeted antioxidants |
JP4590523B2 (ja) | 1997-11-25 | 2010-12-01 | アンティポディーン ファーマシューティカルズ インコーポレイテッド | ミトコンドリアを標的とする抗酸化剤 |
US20080275005A1 (en) | 1998-11-25 | 2008-11-06 | Murphy Michael P | Mitochondrially targeted antioxidants |
US20070270381A1 (en) | 2000-05-25 | 2007-11-22 | Antipodean Pharmaceuticals, Inc. | Mitochondrially targeted antioxidants |
US20020044913A1 (en) | 2000-02-11 | 2002-04-18 | Hamilton Nathan D. | Cosmetics to support skin metabolism |
ITRM20010755A1 (it) | 2001-12-20 | 2003-06-20 | Simonelli Giuseppe | Uso del chinone q10 per il trattamento delle malattie oculari. |
CA2397684A1 (en) | 2002-08-12 | 2004-02-12 | Michael P. Murphy | Mitochondrially targeted antioxidants |
CA2580584C (en) | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
WO2006005759A2 (en) | 2004-07-13 | 2006-01-19 | Oridis Biomed Forschungs- Und Entwicklungs Gmbh | Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
RU2007111720A (ru) | 2004-08-30 | 2008-10-10 | Канека Корпорейшн (Jp) | Активаторы митохондрий |
RU2318500C2 (ru) | 2005-10-18 | 2008-03-10 | Общество С Ограниченной Ответственностью "Митотехнология" | Способ воздействия на организм путем адресной доставки биологически активных веществ в митохондрии, фармацевтическая композиция для его осуществления и соединение, применяемое для этой цели |
EA200900582A1 (ru) | 2006-10-20 | 2009-08-28 | Общество С Ограниченной Ответственностью "Митотехнология" | Фармацевтические композиции для профилактики и лечения глазных патологий |
WO2008094062A1 (fr) * | 2007-01-29 | 2008-08-07 | Limited Liability Company 'mitotechnology' | Compositions pharmaceutiques servant à la prévention et au traitement de maladies oncologiques |
US8518915B2 (en) | 2007-06-29 | 2013-08-27 | Mitotech Sa | Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
US8716486B2 (en) | 2008-06-25 | 2014-05-06 | Edison Pharmaceuticals, Inc. | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
-
2009
- 2009-11-13 AU AU2009355359A patent/AU2009355359B2/en active Active
- 2009-11-13 EP EP09851317A patent/EP2500336A1/en not_active Withdrawn
- 2009-11-13 JP JP2012538785A patent/JP2013510849A/ja active Pending
- 2009-11-13 MX MX2012005356A patent/MX2012005356A/es not_active Application Discontinuation
- 2009-11-13 CA CA2789846A patent/CA2789846C/en active Active
- 2009-11-13 WO PCT/RU2009/000621 patent/WO2011059355A1/ru active Application Filing
- 2009-11-13 CN CN2009801624014A patent/CN102791670A/zh active Pending
- 2009-11-13 CA CA3068007A patent/CA3068007C/en active Active
- 2009-11-13 BR BR112012011197-3A patent/BR112012011197A2/pt not_active Application Discontinuation
- 2009-11-13 UA UAA201207236A patent/UA107476C2/ru unknown
- 2009-11-13 EA EA201200604A patent/EA023248B1/ru not_active IP Right Cessation
- 2009-11-13 KR KR1020127015205A patent/KR20120125980A/ko not_active Application Discontinuation
-
2012
- 2012-05-02 IL IL219533A patent/IL219533A/en active IP Right Grant
- 2012-05-07 ZA ZA2012/03345A patent/ZA201203345B/en unknown
- 2012-05-14 US US13/470,823 patent/US9233903B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20120125980A (ko) | 2012-11-19 |
EA023248B1 (ru) | 2016-05-31 |
EP2500336A1 (en) | 2012-09-19 |
US9233903B2 (en) | 2016-01-12 |
JP2013510849A (ja) | 2013-03-28 |
BR112012011197A2 (pt) | 2020-10-20 |
US20120259110A1 (en) | 2012-10-11 |
AU2009355359A1 (en) | 2012-06-07 |
MX2012005356A (es) | 2013-01-29 |
CA2789846A1 (en) | 2011-05-19 |
CN102791670A (zh) | 2012-11-21 |
AU2009355359B2 (en) | 2016-11-10 |
ZA201203345B (en) | 2013-01-30 |
IL219533A0 (en) | 2012-06-28 |
CA2789846C (en) | 2020-02-25 |
IL219533A (en) | 2017-04-30 |
UA107476C2 (ru) | 2015-01-12 |
CA3068007A1 (en) | 2011-05-19 |
WO2011059355A1 (ru) | 2011-05-19 |
CA3068007C (en) | 2022-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201200604A1 (ru) | Фармацевтические субстанции на основе митохондриальноадресованных антиоксидантов | |
CY1122853T1 (el) | Σταθερα σκευασματα λινακλοτιδης | |
CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
SG10202007194PA (en) | Multispecific antigen-binding molecules having blood coagulation factor viii (fviii) cofactor function-substituting activity and pharmaceutical formulations containing such a molecule as an active ing | |
EA201591166A1 (ru) | Ингибиторы аутотаксина | |
MX2015003653A (es) | Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj. | |
WO2015095227A3 (en) | Peptidomimetic compounds and antibody-drug conjugates thereof | |
EA201200937A1 (ru) | Твердая лекарственная форма тикагрелора | |
EA201391106A1 (ru) | Новые гетероциклические производные | |
CY1120204T1 (el) | Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο | |
EA201500536A1 (ru) | Триазолопиразин | |
EA201201661A1 (ru) | Новые аминопиразолохиназолины | |
MA38096B1 (fr) | Solutions mydriatiques et anti-inflammatoires stables sans agents de conservation destinees a etre injectees | |
BR112012016853A2 (pt) | "composições farmacêuticas para administração oral de peptídeos de insulina". | |
CY1120094T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει despr036 eξenδinh-4(1-39)-lys6-nh2 για χρηση στην θεραπευτικη αγωγη μιας νευροεκφυλιστικης ασθενειας | |
BR112014027981A2 (pt) | compostos do tipo fumagilol e métodos de produção e utilização dos mesmos | |
EA201291211A1 (ru) | Фармацевтические композиции, содержащие гидроморфон и налоксон | |
MX344846B (es) | Combinacion de granulos cargados activos con activos adicionales. | |
EA201500112A1 (ru) | 3-замещенные производные эстра-1,3,5(10),16-тетраена, способы их получения, фармацевтические средства, которые их содержат, и их использование для получения лекарственных средств | |
EA201291050A1 (ru) | Комбинация лекарств с протеинсвязывающими пролекарствами | |
MX340188B (es) | Elaboracion de granulos sin activos y tabletas que comprenden los mismos. | |
NZ702253A (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
WO2015059463A3 (en) | Treatment of beta-catenin related diseases8 | |
EA201301321A1 (ru) | Изготовление и использование пероральных фармацевтических композиций на основе митохондриально-адресованных антиоксидантов | |
DE102009018133A8 (de) | Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM KG MD TJ TM |